Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yellin

Showing results (561-570 of 625) with videos related to

Pageof 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4Kimberly E Beck, Joseph A Blansfield, Khoi Q Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2007
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockadeStephanie G Downey, Jacob A Klapper, Franz O Smith, et al.
Nature Communications|July 11, 2024
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023Juan Manuel Carreño, Abram L Wagner, Brian Monahan, et al.
Blood|January 7, 2009
p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamicsJayme D Allen, Zahara M Jaffer, Su-Jung Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid TumorsHoward A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2019
A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron ConversionYu-Chen Chen, Ning-Xin Ma, Zi-Fei Pei, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|January 19, 2022
Selecting the Next Class: The "Virtual Orthopaedic Rotation"Joseph L Yellin, Laura Y Lu, Andrea S Bauer, et al.
American Journal of Hematology|December 2, 2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acidJames R Berenson, Ori Yellin, John Crowley, et al.
British Journal of Haematology|July 19, 2012
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survivalEric Sanchez, Mingjie Li, Alex Kitto, et al.
Pageof 63

Showing results (561-570 of 625) with videos related to

Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4Kimberly E Beck, Joseph A Blansfield, Khoi Q Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2007
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockadeStephanie G Downey, Jacob A Klapper, Franz O Smith, et al.
Nature Communications|July 11, 2024
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023Juan Manuel Carreño, Abram L Wagner, Brian Monahan, et al.
Blood|January 7, 2009
p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamicsJayme D Allen, Zahara M Jaffer, Su-Jung Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid TumorsHoward A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2019
A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron ConversionYu-Chen Chen, Ning-Xin Ma, Zi-Fei Pei, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|January 19, 2022
Selecting the Next Class: The "Virtual Orthopaedic Rotation"Joseph L Yellin, Laura Y Lu, Andrea S Bauer, et al.
American Journal of Hematology|December 2, 2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acidJames R Berenson, Ori Yellin, John Crowley, et al.
British Journal of Haematology|July 19, 2012
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survivalEric Sanchez, Mingjie Li, Alex Kitto, et al.
Pageof 63